HCAT Health Catalyst, Inc.

NASDAQ
$1.29

Health Catalyst, Inc. (HCAT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus HCAT's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
1
2 transactions
Purchases
$105.4K
59,000 shares
Sales
$141.0K
99,478 shares
Net activity
-$35.5K
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $141.0K 2 transactions · 99,478 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $100.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 14, 2026 , by Kohl Simeon .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Landry Benjamin General Counsel Sell 10b5-1 29,478 $1.39 $41.0K 251,894 −10.5% of holding
Landry Benjamin General Counsel Sell 10b5-1 70,000 $1.43 $100.0K 281,372 −19.9% of holding
Kohl Simeon Chief Executive Officer Buy 59,000 $1.79 $105.4K 2,856,385

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.